[Editorial] Approving new drugs
Thursday, February 23, 2017 - 15:01
in Mathematics & Economics
As the Trump administration takes shape, there is much speculation as to what major changes will be made. A dominant theme of the Trump campaign was to cut through bureaucracy in Washington, D.C., thereby enhancing innovation and bringing new technology to Americans more quickly. Nowhere could such a philosophical change have more impact than on Food and Drug Administration (FDA) approval of new drugs. Author: John L. LaMattina